NMR solution structure of triazole bridged plasmin inhibitor
ID | Type | Value order | Atom ID 1 | Atom ID 2 |
---|---|---|---|---|
1 | covalent | sing | 1:ALA3:CB | 2:WMH1:C |
2 | covalent | sing | 1:ALA11:CB | 2:WMH1:C1 |
3 | covalent | sing | 1:GLY1:N | 1:ASP14:C |
Polymer type: polypeptide(L)
Total | 1H | 13C | 15N | |
---|---|---|---|---|
All | 90.5 % (153 of 169) | 100.0 % (91 of 91) | 76.1 % (51 of 67) | 100.0 % (11 of 11) |
Backbone | 84.6 % (66 of 78) | 100.0 % (26 of 26) | 70.7 % (29 of 41) | 100.0 % (11 of 11) |
Sidechain | 96.2 % (100 of 104) | 100.0 % (65 of 65) | 89.7 % (35 of 39) | |
Aromatic | 77.8 % (14 of 18) | 100.0 % (9 of 9) | 55.6 % (5 of 9) | |
Methyl | 100.0 % (8 of 8) | 100.0 % (4 of 4) | 100.0 % (4 of 4) |
1. entity 1
GRAYKSKPPI AFPDSolvent system 90% H2O/10% D2O, Pressure 1 Pa, Temperature 298 K, pH 3.5, Details 1.5 mM DR12, 90% H2O/10% D2O
# | Name | Isotope labeling | Type | Concentration |
---|---|---|---|---|
1 | DR12 | natural abundance | 1.5 (±0.2) mM |